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Abstract
We sought to investigate whether hypoalbuminaemia was mainly caused by acute or
chronic factors in patients with community-acquired bacteraemia. In this population-based
study, we considered 1844 adult cases of community-acquired bacteraemia that occurred
in Funen, Denmark between 2000 and 2008.We used a stepwise prognostic predisposi-
tion-insult-response-organ dysfunction (PIRO) logistic regressionmodel by initially includ-
ing age and comorbidity, then added bacterial species, and finally sepsis severity. The
models were furthermoreanalysed using receiver operating characteristic (ROC) curves.
Outcomes comprisedmortality incidence on days 0–30 and 31–365 after the bacteraemia
episode. Each step was performedwith and without baseline albumin level measured on
the date of bacteraemia. In 422 patients, their latest albumin measurement taken 8–30 days
before the date of bacteraemiawas also used in the analysis together with the baseline
albumin level. For each decrease of 1g/L in plasma albumin level, the odds ratios (95% con-
fidence intervals) of mortality in the period of 0–30 days after bacteraemiawere 0.86 (0.84–
0.88) in both predisposition (P) and predisposition-insult (PI) models and 0.87 (0.85–0.89)
in the full PIRO-model. The AUC values were 0.78 and 0.66 for mortality in the period of
0–30 days in the model comprising only predisposition factors with and without albumin lev-
els added as a factor, respectively. The AUC values in the full PIRO-model were 0.81 and
0.73 with and without consideration of albumin levels, respectively. A higher proportionof
patients died within 30 days if there was a decrease in the albumin level between days 8
and 30 before bacteraemia and the actual bacteraemia date. A single plasma albumin
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measurement on the bacteraemia date was a better prognostic predictor of short-termmor-
tality than the sepsis severity score.
Introduction
Bacteraemia is most common among elderly patients with chronic comorbid conditions. It
may cause severe sepsis with circulatory disturbances and a compensatory expansion of the
plasma volume and extravasation. In general, it is difficult to assess to what extent a poor out-
come in bacteraemic patients is related to the acute sepsis episode itself or to chronic predispo-
sition factors often encountered in this patient cohort. Hypoalbuminaemia has traditionally
been related to chronic conditions such as liver failure, malnutrition, or protein-losing enterop-
athy [1,2]. However, numerous studies of critically ill patients have indicated that plasma albu-
min (PA) in this population is a negative sign of the acute phase of the pathology and hence, an
inflammation indicator, rather than a nutritional state marker [3–6]. Three processes deter-
mine the PA level: synthesis and secretion from the liver, catabolism, and distribution between
the vascular system and the interstitial space [1,4,7]. The individual impact of each of these
processes on the PA level, however, is difficult to quantify in real-life situations. The knowledge
of disease-related changes in PA level in humans is hampered by the fact that the vast majority
of observational studies only comprise a single albuminmeasurement [8].
In this study, we considered adult cases of community-acquired bacteraemia in order to elu-
cidate if there was a clear association between hypoalbuminaemia and short-term (0–30 days)
or long-term (31–365 days) mortality after bacteraemia, and whether this possible association
was primarily caused by acute or chronic factors.
Materials andMethods
Study population
This study population has been describedpreviously [9]. In brief, it included 2785 adult
patients (>14 years) from the Funen County, Denmark, with an incident community-acquired
bacteraemia between 2000 and 2008. We included 1844 patients who had a PA measurement
on the bacteraemia date, which was defined as the date the blood culture was drawn.
Microbiological data
All blood cultures were submitted to the Department of ClinicalMicrobiology at the Odense
University Hospital, where they were incubated and screened for growth of microorganisms
for six days or until detected positive by the Difco ESP blood culture system (Difco Laborato-
ries, Detroit, MI, USA) in the year 2000 and the Bactec 9240 system (BectonDickinson, Frank-
lin Lakes, NJ, USA) in the years 2001–2008. Identification of microorganisms was based on
conventional approaches [10], the Danish reference program (www.dskm.dk), and automated
identification using Vitek 2 (bioMérieux,Marcy l’Etoile, France).
Albumin level measurements
Albumin levels were measured with a Modular P analyser (Roche,Mannheim, Germany) by
the bromocresol green dye-binding method.
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Community-acquiredbacteremia
We defined the presence of a positive blood culture as evidence of bacteraemia based on clinical
and microbiological criteria [11]. We included all infection episodes, which were associated
with the presence of Staphylococcus spp., Streptococcus spp., Enterococcus spp., Pseudomonas
aeruginosa, or Enterobacteriaceae in the blood. Coagulase-negative staphylococci or non-hae-
molytic streptococci found in only one bottle were considered contamination and these cases
were not included in the analysis.
Bacteraemiawas defined as community-acquired if the bacteraemia date was within 3 days
after admission and there had been no inpatient contact within 7 days up to the bacteraemia date.
Sepsis severity
We looked through the patients’ medical records to retrieve systemic inflammatory response
syndrome (SIRS) parameters [12] as well as descriptions of any central nervous system (CNS)
signs on the admission date. We defined sepsis as the condition when two or more of the three
SIRS parameters were present (temperature>38°C or< 36°C; heart rate> 90 beats/min;
WBC> 12,000 cells/mm3, or WBC< 4,000 cells/mm3, or when over 10%WBCwere repre-
sented by immature forms). The medical records had inconsistent information on the respira-
tory rate or PaCO2 and consequently, this SIRS parameter was ignored. Sepsis was further
categorized as severe sepsis/septic shock if organ dysfunction or hypotension (systolic blood
pressure<90 mmHg) occurred. Because it was not possible to assess the validity of data on the
initial fluid resuscitation, we did not distinguish between severe sepsis and septic shock.We
defined organ dysfunction (CNS, kidney, liver, perfusion, or lung) according to criteria
described earlier [9]. Using the above-mentioned criteria, we divided the patients into the fol-
lowing sepsis categories: no sepsis, possible sepsis (because of missing data), sepsis, severe sep-
sis/septic shock, and organ dysfunctionwithout sepsis.
Linkage to other registries
We linked the study database to the Danish National Patient Registry [13] to retrieve informa-
tion on the first-time occurrence of comorbidity between 1994 and the bacteraemia date. We
used the Charlson comorbidity index that comprises 19 major comorbidity groups with higher
scores being assigned to prognosticallymore severe diseases (e.g., diabetesmellitus, malignancy
and cardiovascular diseases) [14].
Data on mortality were obtained from the Danish Civil Registration System, which contains
records on the health status of all Danish residents as well as dates of death or emigration, if rel-
evant [15].
Statistical analysis
As the PA levels were normally distributed (data not shown), they were compared between
groups defined by population characteristics (gender, age groups, Charlson comorbidity, bacte-
rial groups, and sepsis severity) using the one-way ANOVA test. If ANOVA result was signifi-
cant, the Bonferroni post hoc test was used for pairwise group comparisons. For ordered
groups, we used the non-parametric Cuzick’s method for trend across these groups [16].
For each of the five sepsis severity groups, we computed Kaplan-Meier survival curves that
represented PA level quintiles.
We used the prognostic predisposition-insult-response-organ dysfunction (PIRO) logistic
regression model that comprised variables related to the predisposition (P), insult/infection (I),
and response/organ dysfunction (RO) [17]. This model included the predisposition
Hypoalbuminaemia in Bacteraemia Patients Related to Acute Disorders
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variables”gender”, “age”, “Charlson comorbidity index” (0, 1, and2 points), the insult vari-
able “main bacterial groups” (gram-positive, gram-negative, and others), and the response/
organ dysfunction variable”sepsis severity group” (no sepsis, possible sepsis, sepsis, severe sep-
sis/septic shock, and organ dysfunctionwithout sepsis).
We initially showed that the PA level could be used as a continuous variable in a logistic
regression model with mortality incidence on days 0–30 and 31–365 after bacteraemia as out-
comes, using spline, quintile, and fractional polynomial curves as reported before [18]. To facil-
itate reporting of the results, we subsequently divided the PA level into quintiles.
Logistic regression was used to compute odds ratios (ORs) with 95% confidence intervals
(CIs) for mortality after short (0–30 days) and long periods (31–365 days) following bacterae-
mia. We applied a stepwise approach, in which the first step only included predisposition vari-
ables, then the insult variable was added, and finally the response/organ dysfunction variable
was incorporated in the full model. These steps were performedwith and without the incorpo-
ration of the PA level to assess its impact on the prediction of mortality within short or longer
post-bacteraemiaperiods. For each of the stepwise models, we computed receiver operating
characteristic (ROC) curves and values of the area under these curves (AUC) with 95% CIs.
We reiterated all analyses using Cox proportional hazards regression analysis with hazard
ratios (HRs) and 95% CIs. The HRs (95% CIs) did not deviate materially from the ORs (data
not shown), which was expected as only 1 patient was censored within 365 days. Moreover, as
HRs do not enable subsequent computation of AUCs, we report ORs in this study.
In order to determine whether hypoalbuminaemia had mainly occurred before or was
caused by the bacteraemic episode, we selected patients with PA measured 8–30 days before
the bacteraemia date, i.e., during the periodwhen the patients were believed not to experience
an acute phase response.We retrieved the latest PA level measurements within that period and
plotted them against respective PA levels on the bacteraemia date (the baseline PA level). In
this scatterplot, we further indicated whether the individual patients were alive or dead within
30 days after the bacteraemia date.
Data were considered to be significantly different if p-value< 0.05 in relevant tests. The
Stata software (v.13.1, StataCorp, TX, USA) was used for all analyses.
Ethical considerations
This study was approved by the Danish Data Protection Agency (no. 2013-41-2579). Accord-
ing to Danish legislation, approval by an ethics committee or consent from participants
(including next of kin/caregiver in the case of children) are not required for registry-based
research. Data were not anonymised prior to analysis.
Results
Baseline characteristics
Patients were generally old and had comorbidities. In this study cohort, 53% had severe sepsis
or septic shock (Table 1).
Serumalbumin levels with respect to the population characteristics
PA levels ranged from 11 to 53 g/L. Almost half of the patients (897 [48.6%]) had hypoalbumi-
naemia (<35 g/L) of whom 158 (8.6%) had<25 g/L.
PA levels tended to decline with increasing frailty of the patients, especially for increasing
severity in the sepsis groups (Table 2). Among the sepsis severity groups, a trend test corrobo-
rated the significant p-value by showing decreasing PA levels with an increase in sepsis severity.
Hypoalbuminaemia in Bacteraemia Patients Related to Acute Disorders
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Kaplan-Meier survival curves
Mortality was positively associated with sepsis severity and within all severity groups mortality
incidence negatively correlated with PA levels (Fig 1).
Table 1. Baseline characteristics of the study cohort (n = 1844).
Population characteristics Number (%)
Age, years
Median (25th, 75th percentile) 70.5 (57.1, 79.5)
Mean (minimum,maximum) 67.4 (15.5, 101.7)
Females 817 (44.3)
Charlson comorbidity index
0 points 417 (22.6)
1 point 300 (16.3)
>1 points 1127 (61.1)
Smoking
Never 389 (21.1)
Present 345 (18.7)
Former 190 (10.3)
Unknown 920 (49.9)
Alcohol abuse
Never 698 (37.9)
Present 130 (7.0)
Former 60 (3.3)
Unknown 956 (51.8)
Bacteria
Monomicrobial Gram-positive
Staphylococcus aureus 273 (14.8)
Streptococcus pneumonia 257 (13.9)
Streptococci, other 156 (8.5)
Enterococcus faecalis 44 (2.4)
Monomicrobial Gram-negative
Escherichia coli 633 (34.3)
Klebsiella spp. 102 (5.5)
Pseudomonas aeruginosa 49 (2.7)
Other 145 (7.9)
Polymicrobial 185 (10.0)
Admitted to
Surgical unit 208 (11.3)
Medical unit 1336 (72.5)
Oncology/haematologyunit 217 (11.8)
Intensive care unit 79 (4.3)
Unknown 4 (0.2)
Sepsis severity
No sepsis 108 (5.9)
Possible sepsis 237 (12.9)
Sepsis 415 (22.5)
Severe sepsis or septic shock 977 (53.0)
Organ dysfunctionwithout sepsis 107 (5.8)
doi:10.1371/journal.pone.0160466.t001
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The survival curveswere non-parallel in the 0–30-day period. Beyond 30 days, the survival
curves for the less severe sepsis groups (no sepsis, possible sepsis, and sepsis) continued to have
different curve-slopes,whereas the curves became nearly parallel for the groups with severe
sepsis groups (severe sepsis/septic shock, organ dysfunctionwithout sepsis).
Logistic regression analyses
For the 0–30-day mortality rates, ORs did not change appreciably across the P-, PI-, and
PIRO-models (Table 3). Irrespective of the model, ORs mainly declinedwith comorbidity and
sepsis either with or without addition of PA level. The ORs of the PA level did not change sig-
nificantly between the three models, so that a decrease in PA levels by 1 g/L consistently pre-
dicted a 13–14% higher mortality incidence.
Sepsis severity was not a significant predictor of mortality during the 31–365-day period
(Table 4). In contrast to the 0–30-day mortality, there were only minimal changes in ORs
when PA level was added to the models. As for the 0–30-day mortality, the ORs of PA level
remained fairly constant regardless of the model. The OR of 0.93 meant that a decrease in PA
level by 1 g/L predicted a 7% increase in mortality, i.e., half as much of the PA predicting capac-
ity during the 0–30-day period. The OR was 0.89 for the three less severe conditions, but com-
prised 0.95 for the two groups with more severe pathologies (data not shown), which
corroborated the higher diversions for the former as depicted in Fig 1.
Table 2. Mean plasma albumin levels on the bacteraemiadate for population characteristic groups
among adult community-acquiredbacteraemia patients (n = 1844).
Population characteristic groups Mean serum albumin level (g/L) p-value1
All patients 34.0
Gender 0.10
Males 34.1
Females 33.8
Age (years) 0.002
15–64 34.6 A
65–79 33.4 B
 80 33.8 Ab
Charlson comorbidity points <0.0001
0 35.6 A
1 33.7 B
 2 33.4 B
Bacterial groups 0.01
Monomicrobial Gram-positive 34.4 A
Monomicrobial Gram-negative 33.8 Ac
Polymicrobial 32.5 Bc
Sepsis severity <0.0001
No sepsis 34.8 A
Possibly sepsis 35.6 A
Sepsis 36.4 a
Severe sepsis or septic shock 32.8 b
Organ dysfunctionwithout sepsis 30.4 c
1 For significant p-values, different characters denote significant differences in pairwise comparisons. Distinct
letters indicate significant differences within groups defined by population characteristics.
doi:10.1371/journal.pone.0160466.t002
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The area under the ROC curves
For the 0–30-day mortality, the PA level contributed more to the AUC value (0.78 for the P-
model with PA) than both bacterial and sepsis group factors (0.73 for the PIRO-model without
PA) (Table 5). For the models with PA, there was less impact on the AUC values when the sep-
sis-groups were introduced. Irrespective of the model, the largest relative changes in AUC val-
ues, ranging from 11% to 18%, were seen when PA level was added. All models with PA level
reported an AUC value close to 0.80, which is often considered clinically satisfactory.
For the 31–365-day mortality, the AUC value in the P-model that included the PA level
(0.74) was larger than the AUC value of the PIRO-model without PA (0.72). In contrast to the
case of the 0–30-day mortality, the sepsis-groups contributed very little to the AUC value.
Although the PA level still contributed more to the AUC values than any other amended vari-
able, its impact was much smaller than that for the 0–30-day mortality.
Fig 1. Kaplan-Meier survival curves for five sepsis-groups in the 0–365-day period.For each sepsis group, a separate curve is illustrated for
each quintile of the serumalbumin level.
doi:10.1371/journal.pone.0160466.g001
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Table 3. Logistic regression analyses for the 0–30-daymortality.
Factor P1 P1+albumin PI2 PI2+albumin PIRO3 PIRO3+albumin
Age (years) 1.03 (1.02–1.04)4 1.03 (1.03–1.04) 1.03 (1.02–1.04) 1.04 (1.03–1.05) 1.03 (1.02–1.04) 1.04 (1.03–1.05)
Females 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Males 1.38 (1.09–1.74) 1.53 (1.19–1.97) 1.37 (1.08–1.74) 1.52 (1.18–1.96) 1.28 (1.00–1.63) 1.44 (1.11–1.87)
Charlson 0 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Charlson 1 1.35 (0.87–2.07) 1.07 (0.68–1.70) 1.33 (0.87–2.05) 1.05 (0.66–1.67) 1.29 (0.83–2.00) 1.03 (0.65–1.66)
Charlson 2 2.29 (1.65–3.20) 1.91 (1.34–2.73) 2.31 (1.65–3.22) 1.96 (1.37–2.80) 2.29 (1.63–3.22) 2.03 (1.41–2.92)
Gr+, mono - - 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Gr-, mono - - 0.77 (0.60–0.98) 0.68 (0.52–0.88) 0.80 (0.62–1.03) 0.69 (0.53–0.90)
Others - - 1.25 (0.74–2.11) 1.00 (0.57–1.76) 1.33 (0.77–2.30) 1.08 (0.60–1.93)
No sepsis - - - - 1 (reference) 1 (reference)
Possibly sepsis - - - - 1.06 (0.51–2.20) 1.31 (0.61–2.83)
Sepsis - - - - 0.61 (0.30–1.25) 0.82 (0.38–1.73)
Severe sepsis - - - - 3.03 (1.61–5.67) 2.83 (1.45–5.49)
Organ dysf. - - - - 2.58 (1.21–5.50) 1.62 (0.72–3.63)
Albumin - 0.86 (0.84–0.88) - 0.86 (0.84–0.88) - 0.87 (0.85–0.89)
1Predisposition;
2predisposition and insult/infection;
3predisposition, insult/infection, and response/organ dysfunction;
4odds ratio (95% confidence interval).
doi:10.1371/journal.pone.0160466.t003
Table 4. Logistic regression analyses for the 31–365-day mortality.
Factor P1 P1+albumin PI2 PI2+albumin PIRO3 PIRO3+albumin
Age (years) 1.03 (1.02–1.04)4 1.03 (1.02–1.04) 1.03 (1.02–1.04) 1.03 (1.02–1.04) 1.03 (1.02–1.04) 1.03 (1.02–1.03)
Females 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Males 1.21 (0.93–1.57) 1.26 (0.96–1.64) 1.21 (0.93–1.57) 1.26 (0.96–1.65) 1.18 (0.91–1.54) 1.24 (0.95–1.62)
Charlson 0 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Charlson 1 2.32 (1.32–4.07) 2.16 (1.22–3.81) 2.29 (1.30–4.02) 2.13 (1.21–3.76) 2.29 (1.30–4.03) 2.14 (1.21–3.78)
Charlson 2 7.00 (4.42–11.05) 6.61 (4.16–10.50) 6.90 (4.37–10.92) 6.51 (4.10–10.35) 6.93 (4.38–10.97) 6.57 (4.13–10.45)
Gr+, mono - - 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Gr-, mono - - 1.13 (0.85–1.49) 1.11 (0.84–1.48) 1.15 (0.87–1.52) 1.13 (0.85–1.50)
Others - - 1.82 (0.99–3.36) 1.81 (0.97–3.36) 1.91 (1.03–3.54) 1.89 (1.02–3.54)
No sepsis - - - - 1 (reference) 1 (reference)
Possibly sepsis - - - - 0.74 (0.38–1.41) 0.80 (0.41–1.56)
Sepsis - - - - 0.96 (0.53–1.73) 1.12 (0.61–2.07)
Severe sepsis - - - - 1.25 (0.71–2.19) 1.24 (0.69–2.20)
Organ dysf. - - - - 1.03 (0.48–2.20) 0.83 (0.38–1.81)
Albumin - 0.93 (0.91–0.95) - 0.93 (0.91–0.95) - 0.93 (0.90–0.95)
1Predisposition;
2predisposition and insult/infection;
3predisposition, insult/infection, and response/organ dysfunction;
4odds ratio (95% confidence interval).
doi:10.1371/journal.pone.0160466.t004
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Patients with serumalbumin measurements8–30 days before the
bacteraemia
Among the 1844 patients considered, 422 (23.3%) had one or more PA measurements in the
period from 8 to 30 days before the bacteraemia date. The average number of days from the lat-
est 8–30-day PA measurement to the bacteraemia date was 15.4 ± 6.6 (data not shown). The
average PA level during the latest measurement was 35.3 ± 5.8 g/L (data not shown), i.e., 1.3
g/L higher than the level determined on the bacteraemia date (Table 1).
To visualise the data from those 422 patients, we plotted the latest measured PA level during
the 8–30-day period on the x-axis and the baseline PA level, determined on the bacteraemia
day, on the y-axis (Fig 2). The diagonal line in Fig 2 represents no change in PA levels. Dots,
representing individual patients, below that line indicate that there was a decrease in the PA
level from the 8–30-day period to the bacteraemia date, whereas dots above that line, in
Table 5. Values of the area under the ROC curve (95%confidence interval) (white cells) and% change for differentmodels (grey cells).
0–30 day mortality 31–365 day mortality
Model Without albumin % increase With albumin Without albumin % increase With albumin
P-model1 0.66 (0.64–0.69) 18.2 0.78 (0.76–0.81) 0.71 (0.68–0.74) 4.2 0.74 (0.71–0.77)
% increase 1.5 1.3 1.4 1.4
PI-model2 0.67 (0.64–0.70) 17.9 0.79 (0.76–0.81) 0.72 (0.69–0.74) 4.2 0.75 (0.72–0.77)
% increase 9.0 2.5 0.0 0
PIRO-model3 0.73 (0.70–0.76) 11.0 0.81 (0.79–0.83) 0.72 (0.70–0.75) 4.2 0.75 (0.72–0.78)
1Predisposition (age, gender, comorbidity);
2predisposition and insult/infection (age, gender, comorbidity, main bacterial groups);
3predisposition, insult/infection, and response/organ dysfunction (age, gender, comorbidity, main bacterial groups, sepsis severity groups)
doi:10.1371/journal.pone.0160466.t005
Fig 2. Scatter plot of plasma albumin (PA) levels for 422 patientswho had one or more PA
measurements in the period from 8–30 days before the bacteraemia date.The x-axis depicts the last
measured albumin level in the 8–30-day period and the y-axis depicts the albumin level on the bacteraemia
date. Dots below the diagonal line represent patients with a decline in the albumin level between the last
measurement in the 8–30-day period and themeasurement on the bacteraemia date, whereas dots above
that line represent a corresponding increase in the PA level. Data for patients, who remained alive 30 days
after the bacteraemia date, are represented by crosses, while triangles indicate data for patients who died
within 0–30 days after the bacteraemiadate.
doi:10.1371/journal.pone.0160466.g002
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contrast, point to an increase in the PA level in that period.Most patients had a decrease in
their PA level. Moreover, the distribution of individual cases in Fig 2 was clearly asymmetrical:
in the lower quintiles, relatively more patients had decreased PA levels as compared to PA lev-
els in the higher quintiles.
A visual inspection of the graph suggests that a higher proportion of patients died within 30
days of the bacteraemia episode, when the baseline PA levels were low. Only for patients with
very high albumin levels 8–30 days before the bacteraemia date (data in the 5th quintile), it was
not visually apparent that a higher proportion of them died within 30 days after the bacterae-
mia episode when their PA levels determined on the bacteraemia date were low.
Discussion
We found that the PA level was a strong prognostic mortality predictor for adult community-
acquired bacteraemia patients, especially for the mortality in the short period after the bacter-
aemia episode. To the best of our knowledge, this is the first study that has evaluated PA levels
in relation to both chronic and acute factors in bacteraemia patients by a PIROmodel. This
enabled quantification of the PA level prognostic capacity as compared to the influence of
chronic and acute comorbidities, both of which are common in bacteraemic patients.
Bacteraemia is a serious condition with a 30-day mortality rate of 15–30% [19]. It is difficult
to assess the relative impact of the infection per se and of other conditions on cases with poor
outcomes. In order to better differentiate between predisposition factors (such as old age and
comorbidity) and acute factors related to the septic episode, the PIRO (Predisposition, Insult/
Infection, Response, Organ dysfunction)model was introduced a decade ago [17]. The PIRO
model has proved valid in studies of sepsis patients, as there were highly significant associations
betweenmortality rates and PIRO scores [20,21]. The use of various biomarkers in the PIRO
models has been advocated previously [20,22], but so far only parameters related to white
blood cells (e.g., SIRS criteria) have been included. Other models, such as the SOFA (Sepsis-
related Organ Failure Assessment) [23] or the APACHE (Acute Physiology, Age, Chronic
Health Evaluation) score [24], have also shown high discrimination in mortality prognosis,
though they have not necessarily been superior to the PIRO score [25]. Interestingly, the inclu-
sion of the PA level in APACHE improved its mortality discrimination, after which APACHE
II was renamed APACHE III [24]. In this study, we did not opt for the “perfect” prediction
model, but rather for an explanatory model [26], which could more specifically assess the role
of albumin. Hence, we chose to apply a stepwise PIROmodel approach (P, PI, and PIRO) and
incorporated the baseline PA level in each step to deduce its impact on predisposition factors
representing both chronic conditions and acute factors related to the inflammatory response in
bacteraemia.
We found that a lower baseline PA level independently predicted higher mortality during
the 0–30 and 31–365-day periods after the bacteraemia episode. The predicting capacity was
stronger for mortality in the 0–30-day period.Moreover, the PA level exhibited collinearity
with the sepsis severity, which emphasises the reliability of the baseline PA level as a predictor
of mortality shortly after bacteraemia.Our results obtained after studies of data from a rela-
tively large patient cohort, suggest that a single PA measurement on the bacteraemia date can
be used as a prognostic factor for mortality in the short term after bacteraemiawith better
predictability than the sepsis severity. These findings were corroborated by the weaker effect of
the PA level on the 31–365-day mortality, on which sepsis severity had no prognostic impact.
Finally, lower baseline PA levels for most hypoalbuminaemic patients compared to those mea-
sured within 8–30-day period before the bacteraemia also indicated that hypoalbuminaemia
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primarily reflected acute, rather than chronic, conditions, especially given albumin’s long half-
life of 20 days [7].
Our finding of hypoalbuminaemia as an independent mortality predictor is not novel.
Numerous studies comprising different patient groups, settings, and covariates have unani-
mously confirmed that hypoalbuminaemia predicts a poor outcome [8,27] and this was also
applied to several studies that focused on bacteraemic patients [28–32].
Only a few studies, however, have attempted to assess whether the poor prognosis of
patients with hypoalbuminaemia is mainly related to chronic or acute conditions, which are
both prognostically relevant in bacteraemia patients. One study that comprised Swedish elderly
patients with community-acquired pneumonia [33] and two studies including intensive care
unit patients [34,35] supported our view that hypoalbuminaemiamainly reflected an acute
inflammatory response. Our results are in line with results reported in those studies. The rela-
tion of the PA level to acute conditions was further supported by the decline in the baseline PA
level compared to the latest PA level in the period between 8–30 days before the bacteraemia
episode, especially amongst hypoalbuminaemic patients. We selected the 8–30 day period
assuming that acute conditions related to the bacteraemia, or a possible prior focal infection
(such as pneumonia or urocystitis), would play a minor role (see Fig 2). The role of hypoalbu-
minaemia in acute conditions is further indicated by its inverse correlation with several acute
phase biomarkers [1,2,4,36–41]. In contrast to the sepsis variables, the PA level also predicted
mortality beyond day 30, especially in the groups with less severe disease (no sepsis, possible
sepsis, sepsis). This indicated that the PA level at the time of blood culture to some extent also
reflected the presence of chronic conditions having an impact on survival. In addition, we
detected an inverse correlation between the PA and serumCRP levels (R = -0.21, p< 10−5,
data not shown) in our data; however, we did not include CRP in our models due to the high
collinearity betweenCRP and the sepsis severity parameters detected in our earlier study for
virtually the same study population [9].
Our study was population-based and included a high number of patients with well-defined
bacteraemia for whom complete short- and long-term follow-ups were possible. The study,
however, had some limitations. Firstly, it was not a prospective study and we only had two or
more PA measurements for about 23% of the study population. For these patients, the age and
PA levels did not differ from the remaining 77%, but this group had more comorbidity (data
not shown). They also had higher mortality levels in the 31–365-day period, but this difference
failed to achieve statistical significance after adjusting for comorbidity. We selected the last PA
measurement at least 8 days before the baseline PA measurement to represent a period in
which the impact of an acute event on the PA level was probably minimal. Secondly, we had no
data on the nutritional status, which is traditionally believed to be related to hypoalbuminae-
mia [7,42]. Newer studies have, however, consistently reported a lack of association between
the albumin level and nutrition markers, such as BMI or triceps skinfold thickness [43–45],
indicating that albumin is not a sensitive nutritional marker [2]. Thirdly, only 1844 of 2784
patients (66.2%) had their PA level measured on the bacteraemia date, which compromised the
population-based design. The 940 patients without a PA measurement were older, had less
comorbidity, and were less likely to have sepsis. Fourthly, other prognostic models than PIRO,
e.g. SOFA [23] or APACHE III [24] could have been applied, but this was not possible due to
lack of data in our retrospective study. There is much discussion on which model is the best to
predict morbidity or mortality [26,46], which probably also differs between patient groups and
settings [25]. In this study, we preferred an explanatory model in which we focused on one pre-
dictor (the PA level), in contrast to a predictionmodel that assesses all relevant predictors
which together render the best prognostic discrimination [26]. We found that the PIROmodel,
due to its stepwise approach and ability to distinguish between chronic and acute factors, was a
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suitable hypothesis-generating explanatory model [17]. Finally, due to missing data it was
unclear if some of the patients had sepsis or not. We reiterated all the analyses with these
patients as either having no sepsis or sepsis, but that manipulation did not change the results
significantly (data not shown).
In conclusion, the baseline PA level was a strong prognostic mortality predictor for adult
community-acquired bacteraemia patients, especially for mortality shortly after the bacterae-
mic episode. Its negative correlation with mortality rates during day 0–30 and 31–365 did not
change after an adjustment with chronic or acute factors. Moreover, for the short-termmortal-
ity, PA level was a stronger predictor than sepsis severity indices based on the commonly used
SIRS criteria and organ dysfunction parameters [12]. This retrospective study indicates that
hypoalbuminaemia was mainly caused by factors related to the acute response per se. Prospec-
tive studies with longitudinal PA measurements are necessary to further elaborate dynamics of
albumin level changes in relation to acute conditions. However, this can only be achieved in
patients, which are followed routinely due to other diseases.
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